The Effects of Huang-Lian-Jie-Du-Tang（HLJDT) on the Survival of Patients With Multiple Myeloma in Maintain Therapy

NCT02467647 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Thalidomide
DRUG: HLJDT

Sponsor

Wuhan University

Collaborators

[object Object]